BioFocus DPI and Oncodesign to work together on oncology drug discovery

BioFocus DPI of Saffron Walden, UK and Oncodesign of France have joined forces to offer an oncology drug discovery service.

The alliance combines BioFocus DPI's target discovery and screening capabilities with Oncodesign's experimental pharmacological and biomarker expertise in oncology. In addition, the partners will pool their complementary medicinal chemistry expertise to form a drug discovery service specialised in the rapid generation of promising anticancer drug candidates.

"As the industry's understanding of disease pathways has grown considerably in recent years, the need for specialised drug discovery services has also grown," said Chris Newton, senior vice president of BioFocus DPI. "We expect that our current and future customers will benefit greatly from the synergies that this alliance offers."